Matthias Guckenberger, Chairman at University Hospital Zurich, shared on LinkedIn:
“You are uncertain about the safety profile of Stereotactic Radiotherapy in a patient concomitantly treated with a novel drug․
You try following the literature but cannot keep-up with the rapidly evolving evidence․
The LINACS project and the website below will provide most up-to-date information and guidance․
A a living systematic review of the safety of concurrent stereotactic radiotherapy and novel systemic therapies by the European Society for Radiotherapy and Oncology (ESTRO), EORTC – European Organisation for Research and Treatment of Cancer, OligoCare Consortium․
Title: LINACS: a living systematic review of the safety of concurrent stereotactic radiotherapy and novel systemic therapies by the ESTRO/EORTC OligoCare Consortium
Authors: Nora Sundahl, Esmée Lauren Looman, Luc Ollivier, Matteo Bagnalasta, Piet Ost, Matthias Guckenberger, Jeffrey Ryckman, Matthew Culbert, Geertruida Bekkering, Sabrina Reichl
Other articles about Radiotherapy on OncoDaily.